HEADER LIGASE 26-SEP-23 8QNG TITLE CRYSTAL STRUCTURE OF THE E3 UBIQUITIN LIGASE CBL-B WITH AN ALLOSTERIC TITLE 2 INHIBITOR (BENZODIAZEPINE HTS HIT COMPOUND 1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CBL-B; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CBLB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS E3 UBIQUITIN LIGASE, ALLOSTERIC INHIBITION, STRUCTURE BASED DRUG KEYWDS 2 DESIGN, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL REVDAT 3 03-JAN-24 8QNG 1 JRNL REVDAT 2 06-DEC-23 8QNG 1 JRNL REVDAT 1 22-NOV-23 8QNG 0 JRNL AUTH J.A.BOERTH,A.J.CHINN,M.SCHIMPL,G.BOMMAKANTI,C.CHAN,E.L.CODE, JRNL AUTH 2 K.A.GIBLIN,A.GOHLKE,C.S.HANSEL,M.JIN,S.L.KAVANAGH,M.L.LAMB, JRNL AUTH 3 J.S.LANE,C.J.B.LARNER,A.M.MFUH,R.K.MOORE,T.PURI,T.R.QUINN, JRNL AUTH 4 M.YE,K.J.ROBBINS,M.GANCEDO-RODRIGO,H.TANG,J.WALSH,J.WARE, JRNL AUTH 5 G.L.WRIGLEY,I.K.REDDY,Y.ZHANG,N.P.GRIMSTER JRNL TITL DISCOVERY OF A NOVEL BENZODIAZEPINE SERIES OF CBL-B JRNL TITL 2 INHIBITORS FOR THE ENHANCEMENT OF ANTITUMOR IMMUNITY. JRNL REF ACS MED.CHEM.LETT. V. 14 1848 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 38116444 JRNL DOI 10.1021/ACSMEDCHEMLETT.3C00439 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 59.6 REMARK 3 NUMBER OF REFLECTIONS : 11942 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 586 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 30 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 8.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 412 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2885 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 388 REMARK 3 BIN R VALUE (WORKING SET) : 0.2831 REMARK 3 BIN FREE R VALUE : 0.3699 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.83 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3087 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 20 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.47510 REMARK 3 B22 (A**2) : -6.80790 REMARK 3 B33 (A**2) : 7.28310 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.388 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.861 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3200 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4328 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1120 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 536 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3200 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 410 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2643 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.91 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.89 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.44 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 19.7014 15.9838 28.2176 REMARK 3 T TENSOR REMARK 3 T11: -0.1258 T22: -0.2452 REMARK 3 T33: -0.0606 T12: 0.0241 REMARK 3 T13: 0.0790 T23: -0.0048 REMARK 3 L TENSOR REMARK 3 L11: 2.3810 L22: 3.1367 REMARK 3 L33: 1.6763 L12: 0.3980 REMARK 3 L13: -0.2123 L23: -0.0184 REMARK 3 S TENSOR REMARK 3 S11: 0.1927 S12: -0.0540 S13: -0.0878 REMARK 3 S21: -0.0328 S22: -0.1284 S23: 0.0975 REMARK 3 S31: -0.0773 S32: -0.0558 S33: -0.0643 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QNG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1292133602. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11958 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.197 REMARK 200 RESOLUTION RANGE LOW (A) : 47.944 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 59.7 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 1.10900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9 % PEG8000, 0.05 M MGACETATE, 0.05 M REMARK 280 PCTP PH 7.5, PH 8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.78900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.39300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.02250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.39300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.78900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.02250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 34 REMARK 465 MET A 35 REMARK 465 PRO A 36 REMARK 465 LYS A 37 REMARK 465 THR A 348 REMARK 465 PRO A 349 REMARK 465 HIS A 350 REMARK 465 ASP A 351 REMARK 465 HIS A 352 REMARK 465 ILE A 353 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 38 CG CD OE1 NE2 REMARK 470 LYS A 51 CG CD CE NZ REMARK 470 ASN A 69 CG OD1 ND2 REMARK 470 GLU A 135 CD OE1 OE2 REMARK 470 ASP A 169 CG OD1 OD2 REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 HIS A 312 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 346 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 ARG A 412 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 ILE A 422 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 129 -126.92 48.83 REMARK 500 ALA A 262 -135.14 60.82 REMARK 500 ARG A 291 45.82 -160.48 REMARK 500 ASN A 313 37.77 39.43 REMARK 500 TYR A 329 73.31 -111.81 REMARK 500 SER A 368 45.14 -80.69 REMARK 500 ILE A 375 -61.06 -106.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 504 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 221 OD1 REMARK 620 2 THR A 223 OG1 95.1 REMARK 620 3 ASN A 225 OD1 83.2 70.7 REMARK 620 4 TYR A 227 O 88.8 152.9 83.3 REMARK 620 5 GLU A 232 OE1 134.5 103.1 142.1 92.8 REMARK 620 6 GLU A 232 OE2 89.5 77.1 146.1 129.8 55.7 REMARK 620 7 HOH A 605 O 157.0 62.4 84.4 108.9 61.3 90.1 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 502 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 373 SG REMARK 620 2 CYS A 376 SG 109.8 REMARK 620 3 CYS A 393 SG 102.0 111.6 REMARK 620 4 CYS A 396 SG 101.8 118.9 110.9 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 503 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 408 SG REMARK 620 2 CYS A 411 SG 87.9 REMARK 620 N 1 DBREF 8QNG A 36 427 UNP Q13191 CBLB_HUMAN 36 427 SEQADV 8QNG HIS A 34 UNP Q13191 EXPRESSION TAG SEQADV 8QNG MET A 35 UNP Q13191 EXPRESSION TAG SEQRES 1 A 394 HIS MET PRO LYS GLN ALA ALA ALA ASP ARG ARG THR VAL SEQRES 2 A 394 GLU LYS THR TRP LYS LEU MET ASP LYS VAL VAL ARG LEU SEQRES 3 A 394 CYS GLN ASN PRO LYS LEU GLN LEU LYS ASN SER PRO PRO SEQRES 4 A 394 TYR ILE LEU ASP ILE LEU PRO ASP THR TYR GLN HIS LEU SEQRES 5 A 394 ARG LEU ILE LEU SER LYS TYR ASP ASP ASN GLN LYS LEU SEQRES 6 A 394 ALA GLN LEU SER GLU ASN GLU TYR PHE LYS ILE TYR ILE SEQRES 7 A 394 ASP SER LEU MET LYS LYS SER LYS ARG ALA ILE ARG LEU SEQRES 8 A 394 PHE LYS GLU GLY LYS GLU ARG MET TYR GLU GLU GLN SER SEQRES 9 A 394 GLN ASP ARG ARG ASN LEU THR LYS LEU SER LEU ILE PHE SEQRES 10 A 394 SER HIS MET LEU ALA GLU ILE LYS ALA ILE PHE PRO ASN SEQRES 11 A 394 GLY GLN PHE GLN GLY ASP ASN PHE ARG ILE THR LYS ALA SEQRES 12 A 394 ASP ALA ALA GLU PHE TRP ARG LYS PHE PHE GLY ASP LYS SEQRES 13 A 394 THR ILE VAL PRO TRP LYS VAL PHE ARG GLN CYS LEU HIS SEQRES 14 A 394 GLU VAL HIS GLN ILE SER SER GLY LEU GLU ALA MET ALA SEQRES 15 A 394 LEU LYS SER THR ILE ASP LEU THR CYS ASN ASP TYR ILE SEQRES 16 A 394 SER VAL PHE GLU PHE ASP ILE PHE THR ARG LEU PHE GLN SEQRES 17 A 394 PRO TRP GLY SER ILE LEU ARG ASN TRP ASN PHE LEU ALA SEQRES 18 A 394 VAL THR HIS PRO GLY TYR MET ALA PHE LEU THR TYR ASP SEQRES 19 A 394 GLU VAL LYS ALA ARG LEU GLN LYS TYR SER THR LYS PRO SEQRES 20 A 394 GLY SER TYR ILE PHE ARG LEU SER CYS THR ARG LEU GLY SEQRES 21 A 394 GLN TRP ALA ILE GLY TYR VAL THR GLY ASP GLY ASN ILE SEQRES 22 A 394 LEU GLN THR ILE PRO HIS ASN LYS PRO LEU PHE GLN ALA SEQRES 23 A 394 LEU ILE ASP GLY SER ARG GLU GLY PHE TYR LEU TYR PRO SEQRES 24 A 394 ASP GLY ARG SER TYR ASN PRO ASP LEU THR GLY LEU CYS SEQRES 25 A 394 GLU PRO THR PRO HIS ASP HIS ILE LYS VAL THR GLN GLU SEQRES 26 A 394 GLN TYR GLU LEU TYR CYS GLU MET GLY SER THR PHE GLN SEQRES 27 A 394 LEU CYS LYS ILE CYS ALA GLU ASN ASP LYS ASP VAL LYS SEQRES 28 A 394 ILE GLU PRO CYS GLY HIS LEU MET CYS THR SER CYS LEU SEQRES 29 A 394 THR ALA TRP GLN GLU SER ASP GLY GLN GLY CYS PRO PHE SEQRES 30 A 394 CYS ARG CYS GLU ILE LYS GLY THR GLU PRO ILE ILE VAL SEQRES 31 A 394 ASP PRO PHE ASP HET W89 A 501 34 HET ZN A 502 1 HET ZN A 503 1 HET NA A 504 1 HETNAM W89 2-(MORPHOLIN-4-YLMETHYL)-~{N}-[(3~{S})-2-OXIDANYLIDENE- HETNAM 2 W89 5-PHENYL-1,3-DIHYDRO-1,4-BENZODIAZEPIN-3-YL]BENZAMIDE HETNAM ZN ZINC ION HETNAM NA SODIUM ION FORMUL 2 W89 C27 H26 N4 O3 FORMUL 3 ZN 2(ZN 2+) FORMUL 5 NA NA 1+ FORMUL 6 HOH *20(H2 O) HELIX 1 AA1 ASP A 42 GLN A 61 1 20 HELIX 2 AA2 ASN A 62 GLN A 66 5 5 HELIX 3 AA3 TYR A 73 LYS A 91 1 19 HELIX 4 AA4 ASP A 94 ASN A 104 1 11 HELIX 5 AA5 ASN A 104 LYS A 129 1 26 HELIX 6 AA6 GLU A 130 GLU A 134 5 5 HELIX 7 AA7 SER A 137 PHE A 161 1 25 HELIX 8 AA8 PRO A 162 GLN A 165 5 4 HELIX 9 AA9 GLN A 167 PHE A 171 5 5 HELIX 10 AB1 LYS A 175 GLY A 187 1 13 HELIX 11 AB2 TRP A 194 GLU A 203 1 10 HELIX 12 AB3 SER A 209 ASP A 221 1 13 HELIX 13 AB4 VAL A 230 PHE A 240 1 11 HELIX 14 AB5 PRO A 242 GLY A 244 5 3 HELIX 15 AB6 SER A 245 ALA A 254 1 10 HELIX 16 AB7 THR A 265 LYS A 275 1 11 HELIX 17 AB8 CYS A 289 LEU A 292 5 4 HELIX 18 AB9 PRO A 315 GLU A 326 1 12 HELIX 19 AC1 THR A 356 GLY A 367 1 12 HELIX 20 AC2 CYS A 393 GLU A 402 1 10 SHEET 1 AA1 2 ILE A 191 PRO A 193 0 SHEET 2 AA1 2 TYR A 227 SER A 229 -1 O ILE A 228 N VAL A 192 SHEET 1 AA2 4 TYR A 260 PHE A 263 0 SHEET 2 AA2 4 SER A 282 LEU A 287 1 O LEU A 287 N ALA A 262 SHEET 3 AA2 4 TRP A 295 VAL A 300 -1 O VAL A 300 N SER A 282 SHEET 4 AA2 4 ILE A 306 THR A 309 -1 O THR A 309 N ILE A 297 SHEET 1 AA3 3 TYR A 260 PHE A 263 0 SHEET 2 AA3 3 SER A 282 LEU A 287 1 O LEU A 287 N ALA A 262 SHEET 3 AA3 3 TYR A 331 PRO A 332 1 O TYR A 331 N TYR A 283 SHEET 1 AA4 3 LEU A 391 MET A 392 0 SHEET 2 AA4 3 VAL A 383 GLU A 386 -1 N VAL A 383 O MET A 392 SHEET 3 AA4 3 GLY A 417 PRO A 420 -1 O GLU A 419 N LYS A 384 LINK OD1 ASP A 221 NA NA A 504 1555 1555 2.37 LINK OG1 THR A 223 NA NA A 504 1555 1555 2.54 LINK OD1 ASN A 225 NA NA A 504 1555 1555 2.33 LINK O TYR A 227 NA NA A 504 1555 1555 2.43 LINK OE1 GLU A 232 NA NA A 504 1555 1555 2.46 LINK OE2 GLU A 232 NA NA A 504 1555 1555 2.24 LINK SG CYS A 373 ZN ZN A 502 1555 1555 2.80 LINK SG CYS A 376 ZN ZN A 502 1555 1555 2.17 LINK SG CYS A 393 ZN ZN A 502 1555 1555 2.32 LINK SG CYS A 396 ZN ZN A 502 1555 1555 2.32 LINK SG CYS A 408 ZN ZN A 503 1555 1555 2.28 LINK SG CYS A 411 ZN ZN A 503 1555 1555 2.73 LINK NA NA A 504 O HOH A 605 1555 1555 2.70 CISPEP 1 PRO A 71 PRO A 72 0 5.75 CISPEP 2 GLN A 241 PRO A 242 0 3.26 CISPEP 3 GLU A 386 PRO A 387 0 6.91 CRYST1 55.578 72.045 94.786 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017993 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013880 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010550 0.00000